2001
Day-to-day reproducibility of mental stress-induced abnormal left ventricular function response in patients with coronary artery disease and its relationship to autonomic activation
Jain D, Joska T, Lee F, Burg M, Lampert R, Zaret B. Day-to-day reproducibility of mental stress-induced abnormal left ventricular function response in patients with coronary artery disease and its relationship to autonomic activation. Journal Of Nuclear Cardiology 2001, 8: 347-355. PMID: 11391305, DOI: 10.1067/mnc.2001.113517.Peer-Reviewed Original ResearchMeSH KeywordsAgedAutonomic Nervous SystemBlood PressureCoronary DiseaseHeart RateHumansMaleMiddle AgedObserver VariationReproducibility of ResultsStress, PhysiologicalStroke VolumeVentricular Dysfunction, LeftConceptsCoronary artery diseaseSystolic blood pressureLV ejection fractionLV dysfunctionRate-pressure productBlood pressureAnger recallMS taskHeart rate variabilityAutonomic activationLVEF responseArtery diseaseMental stressSympathetic activationHeart rateSymptomatic coronary artery diseaseRate variabilityAbnormal LVEF responseVentricular function responseChronic stable anginaExercise-induced ischemiaLeft ventricular dysfunctionAdverse prognostic signLF/HFCardiac medications
2000
The feasibility of high-dose chemotherapy in breast cancer patients with impaired left ventricular function
Rose M, Lee F, Gollerkeri A, D'Andrea E, Psyrri A, Bdolah-Abram T, Burtness B. The feasibility of high-dose chemotherapy in breast cancer patients with impaired left ventricular function. Bone Marrow Transplantation 2000, 26: 133-139. PMID: 10918422, DOI: 10.1038/sj.bmt.1702449.Peer-Reviewed Original ResearchMeSH KeywordsAdultAntineoplastic Combined Chemotherapy ProtocolsBreast NeoplasmsCombined Modality TherapyCyclophosphamideDoxorubicinFemaleFollow-Up StudiesHematopoietic Stem Cell MobilizationHematopoietic Stem Cell TransplantationHumansMiddle AgedNeutropeniaPaclitaxelStroke VolumeSurvival RateVentricular Dysfunction, LeftConceptsLeft ventricular ejection fractionHigh-dose chemotherapyBreast cancer patientsMean absolute decreaseCancer patientsAbsolute decreaseLV functionCell rescueImpaired left ventricular functionHigh-dose thiotepaImpaired LV functionHigh-dose melphalanStem cell rescueSymptomatic heart failureCourses of chemotherapyVentricular ejection fractionLeft ventricular functionSequential paclitaxelMetastatic diseaseCardiac deathCardiac symptomsEjection fractionHeart failureVentricular functionCardiac toxicity
1995
Introduction
Elefteriades J, Lee F, Letsou G. Introduction. Cardiology Clinics 1995, 13: 1-3. PMID: 7796423, DOI: 10.1016/s0733-8651(18)30057-2.Peer-Reviewed Original ResearchConceptsSevere left ventricular dysfunctionLeft ventricular ejection fractionAutomatic defibrillator implantationCoronary bypass surgeryLeft ventricular dysfunctionVentricular ejection fractionSpecific patient groupsAdvanced treatment modalitiesHeart transplantationVentricular aneurysmectomyVentricular dysfunctionBypass surgeryDefibrillator implantationValve replacementEjection fractionCardiology clinicPatient groupTreatment modalitiesClinical studiesLeft ventricleTraditional modalitiesModalitiesAneurysmectomyPatientsSurgerySynthesis Guidelines for Selection Among Treatment Options
Elefteriades J, Letsou G, Lee F. Synthesis Guidelines for Selection Among Treatment Options. Cardiology Clinics 1995, 13: 137-143. PMID: 7796428, DOI: 10.1016/s0733-8651(18)30070-5.Peer-Reviewed Original ResearchMedical Therapy and Prognosis in Chronic Heart Failure Lessons from Clinical Trials
Ramahi T, Lee F. Medical Therapy and Prognosis in Chronic Heart Failure Lessons from Clinical Trials. Cardiology Clinics 1995, 13: 5-26. PMID: 7796432, DOI: 10.1016/s0733-8651(18)30058-4.Peer-Reviewed Original ResearchMeSH KeywordsCardiotonic AgentsClinical Trials as TopicDiureticsHeart FailureHumansPrognosisRandomized Controlled Trials as TopicVasodilator AgentsVentricular Dysfunction, LeftConceptsChronic heart failureLeft ventricular dysfunctionIntermediate-term improvementVentricular dysfunctionClinical trialsHeart failureLong-term improvementHemodynamic improvementLong-term effectsFunctional capacityShort-term hemodynamic improvementSystolic left ventricular dysfunctionChronic left ventricular dysfunctionACE inhibitor therapyRole of diureticsImmediate symptomatic reliefMajor clinical trialsSympathetic nervous systemMarker of prognosisGoal of therapyPure vasodilationAldosterone systemDirect vasodilatorAcute stabilizationPharmacologic therapy